CLINICAL_TRIALS
trial_result
· 2013-02-08
Clinical Trial Update: Cyclosporine in Treating Patients With Recurrent or Refractory Angioimmunoblastic T-Cell Lymphoma [Phase 2]
Summary
Phase 2 trial update on cyclosporine for recurrent or refractory angioimmunoblastic T-cell lymphoma; study terminated with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Eastern Cooperative Oncology Group | Conditions: Lymphoma | Phase 2 | Status: TERMINATED | Results posted: 2013-02-08